Proud to be part of this important work. Lancet Breast Cancer Commission highlights the global inequities in breast cancer care.

Congratulations Dr. Susan K. Boolbol and Jennifer Gass on an amazing information packed meeting #asbrs24 . Huge success with record breaking attendance. Everyone travel home safely.

Data from ispy2 shows IM lymphadenopathy in patients treated with neoadjuvant chemotherapy does not negatively impact outcome. #asbrs24 ⁦I-SPY 2⁩ Mara Piltin⁩ ⁦Mayo Clinic Department of Surgery⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩

Great posters from ⁦Mayo Clinic Department of Surgery⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩ presented at #asbrs24 last night. ⁦Tina J Hieken MD⁩

Mayo breast fellows who trained in US percutaneous biopsy with Dr Ricky Fine & Dr Michael Berry during their fellowship ⁦Mayo Clinic Department of Surgery⁩ ⁦Mara Piltin⁩ ⁦Dr. Lillian Erdahl MD⁩ ⁦Arielle Stafford, MD⁩ ⁦Tony Nguyen⁩ ⁦Akiko Chiba, MD, FACS⁩ ⁦⁦Zahraa Al-Hilli⁩

Great evening with Mayo alumni -what a great group #asbrs24 ⁦Mayo Clinic Department of Surgery⁩ ⁦James Jakub⁩ Mara Piltin⁩ ⁦Dr. Lillian Erdahl MD⁩ ⁦Robby Pride⁩ ⁦Akiko Chiba, MD, FACS⁩ ⁦Tony Nguyen⁩ ⁦Arielle Stafford, MD⁩ ⁦Miraj Shah-Khan, MD FACS⁩ ⁦Brittany Murphy⁩

TAD in inflammatory breast cancer. Hypothesis generating work that the clipped node accurately reflects the axillary status #asbrs24 ⁦Mayo Clinic Department of Surgery⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦Tina J Hieken MD⁩

⁦Anna Weiss⁩ presenting at #asbrs24 results from ASBrS survey of practice patterns of omission of ALND after NAC despite lack of prospective data.

Delighted and honored to work with our great board of directors and staff. Excited for the great work we can do together - ASBrS 2024-2025!

Hanging with Asbs24 president Dr. Susan K. Boolbol,
2024 Program chair Jennifer Gass
and 2025 program chair Kari Rosenkranz #asbs24

⁦James Jakub⁩ presenting on prospective trial of immediate lymphatic reconstruction at time of ALND showing no difference in lymphedema rates #asbs24 ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦Mara Piltin⁩

#asbs24 presentation by Kayla Switalla on the ISPY2 trial demonstrating increasing use of clip placement in patients with positive nodes. Data demonstrates that clip placement is beneficial and increases use of TAD ⁦I-SPY 2⁩

Excited for the start of a great meeting. Program looks awesome. Great work Jennifer Gass and Dr. Susan K. Boolbol #ASBRS24

Great meeting and hearing from all the ASBrS committee chairs and vice chairs about the goals for the upcoming year. So many great projects underway #ASBRS24

Just landed in Orlando. Excited for #ASBRS24 - great sessions, catching up with old friends and making new ones.

The role of immune activation on the prognosis of early TNBC if chemotherapy is not given - Roberto Leon-Ferre
JAMA

#BreastCancer #Cancer #Cancer Research #JAMA #NCCN #OncoDaily #Oncology #PrecisionMedicine #PrognosticFactors #SystemicTherapy

oncodaily.com/44309.html

#ASBRS24 Starts Next Week! Download the Meeting App today by simply searching “ASBrS Annual Meetings” in the App Store or Google Play Store and downloading it to your device. Can't wait to see everyone in Orlando!

Dr Katie Eckert, breast surgical oncology fellow presents impact of in breast tumor progression during NAC on survival. ⁦Mayo Clinic Department of Surgery⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦Matthew Goetz⁩ patients with progression have poorer outcomes.

⁦⁩ interesting data on change in biomarker profile after neoadjuvant chemotherapy #SSO2024 consider retesting biomarkers. ⁦I-SPY 2⁩

⁦Mayo Clinic Department of Surgery⁩ breast surgical oncology fellow Jennifer Carroll presenting at #SSO2024 on importance of clinical stage at presentation on patient outcome after neoadjuvant chemotherapy ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦Roberto Leon-Ferre⁩